These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24638005)

  • 1. End points in anal cancer: hopes for a common language.
    Glynne-Jones R; Adams RA; Jitlal M; Meadows H
    J Clin Oncol; 2014 Apr; 32(12):1281-2. PubMed ID: 24638005
    [No Abstract]   [Full Text] [Related]  

  • 2. Interim analyses in clinical trials: why do we plan them?
    Fossâ SD; Skovlund E
    J Clin Oncol; 2000 Dec; 18(24):4007-8. PubMed ID: 11118460
    [No Abstract]   [Full Text] [Related]  

  • 3. Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
    Benson AB; Venook AP; Al-Hawary MM; Cederquist L; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Engstrom PF; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wuthrick E; Gregory KM; Freedman-Cass DA
    J Natl Compr Canc Netw; 2018 Jul; 16(7):852-871. PubMed ID: 30006428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why overall survival should not be the sole valid primary endpoint of phase 3 ovarian cancer chemotherapy trials.
    Markman M
    Gynecol Oncol; 2007 Aug; 106(2):279-81. PubMed ID: 17662376
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidermoid cancer of the anus.
    Greenall MJ; Quan SH; DeCosse JJ
    Br J Surg; 1985 Sep; 72 Suppl():S97-103. PubMed ID: 3899272
    [No Abstract]   [Full Text] [Related]  

  • 6. Locally Recurrent Disease Related to Anal Canal Cancers.
    Sammour T; Rodriguez-Bigas MA; Skibber JM
    Surg Oncol Clin N Am; 2017 Jan; 26(1):115-125. PubMed ID: 27889030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive treatment approach for cloacogenic carcinoma of the anorectum: report from a single cancer center.
    Bertani E; Chiappa A; Mazzarol G; Contino G; Lazzari R; Zampino MG; Viale G; Andreoni B
    Dig Surg; 2010; 27(4):297-301. PubMed ID: 20689291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anal squamous cell carcinoma: an evolution in disease and management.
    Osborne MC; Maykel J; Johnson EK; Steele SR
    World J Gastroenterol; 2014 Sep; 20(36):13052-9. PubMed ID: 25278699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
    Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
    J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoradiation for anal cancer: the more things change, the more they stay the same.
    Fuller CD; Thomas CR
    Oncology (Williston Park); 2010 Apr; 24(5):427-30. PubMed ID: 20480742
    [No Abstract]   [Full Text] [Related]  

  • 11. Anal squamous cell cancer nodal metastases: prognostic significance and therapeutic considerations.
    Cohen AM; Wong WD
    Surg Oncol Clin N Am; 1996 Jan; 5(1):203-10. PubMed ID: 8789503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Immunotherapy in the Treatment of Squamous Cell Carcinoma of the Anal Canal.
    Morris VK; Eng C
    J Natl Compr Canc Netw; 2018 Jul; 16(7):903-908. PubMed ID: 30006430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of the Primary Tumor in Anal Canal Cancers.
    Glynne-Jones R; Rao S
    Surg Oncol Clin N Am; 2017 Jan; 26(1):73-90. PubMed ID: 27889038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial.
    Glynne-Jones R; Sebag-Montefiore D; Meadows HM; Cunningham D; Begum R; Adab F; Benstead K; Harte RJ; Stewart J; Beare S; Hackshaw A; Kadalayil L;
    Lancet Oncol; 2017 Mar; 18(3):347-356. PubMed ID: 28209296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surrogate End Points and Their Validation in Oncology Clinical Trials.
    Zhao F
    J Clin Oncol; 2016 May; 34(13):1436-7. PubMed ID: 26951314
    [No Abstract]   [Full Text] [Related]  

  • 16. Anal canal and perianal epidermoid cancers.
    Fuchshuber PR; Rodriguez-Bigas M; Weber T; Petrelli NJ
    J Am Coll Surg; 1997 Nov; 185(5):494-505. PubMed ID: 9358099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermoid carcinoma of the anus.
    Boey J; Wong J; Ong GB
    Aust N Z J Surg; 1982 Oct; 52(5):521-4. PubMed ID: 6959602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.
    Kramar A; Negrier S; Sylvester R; Joniau S; Mulders P; Powles T; Bex A; Bonnetain F; Bossi A; Bracarda S; Bukowski R; Catto J; Choueiri TK; Crabb S; Eisen T; El Demery M; Fitzpatrick J; Flamand V; Goebell PJ; Gravis G; Houédé N; Jacqmin D; Kaplan R; Malavaud B; Massard C; Melichar B; Mourey L; Nathan P; Pasquier D; Porta C; Pouessel D; Quinn D; Ravaud A; Rolland F; Schmidinger M; Tombal B; Tosi D; Vauleon E; Volpe A; Wolter P; Escudier B; Filleron T;
    Ann Oncol; 2015 Dec; 26(12):2392-8. PubMed ID: 26371288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anal margin cancer: current situation and ongoing trials.
    Jiang Y; Ajani JA
    Curr Opin Oncol; 2012 Jul; 24(4):448-53. PubMed ID: 22581355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on anal cancer diagnosis and treatment.
    Salmo E; Haboubi N
    Pol Przegl Chir; 2011 Feb; 83(2):108-16. PubMed ID: 22166290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.